Literature DB >> 9372695

Factors influencing indoor concentrations of nitric oxide in a Parisian intensive care unit.

E Mourgeon1, E Levesque, C Duveau, J D Law-Koune, B Charbit, E Ternissien, P Coriat, J J Rouby.   

Abstract

In low concentrations, inhaled nitric oxide (NO) increases arterial oxygenation in patients with severe acute respiratory distress syndrome. When present in the ambient atmosphere, NO and its oxidative derivate, nitrogen dioxide (NO2), are considered pollutants. The aim of this study was to assess whether the administration of inhaled NO to mechanically ventilated patients was associated with an increased risk of exposure to NO and NO2 for medical and paramedical staff. During a 1-yr period, indoor and outdoor NO and NO2 concentrations were measured using chemiluminescence in a 14-bed intensive care unit (ICU) to assess the possible influence of therapeutic NO administration on indoor pollution. Ambient concentrations of NO within the ICU were 237 +/- 147 parts per billion (ppb) during periods of NO administration and 289 +/- 147 ppb during periods without NO administration (mean +/- SD, NS). Indoor concentrations of NO and NO2 were entirely dependent on outdoor concentrations and were mainly influenced by climatic conditions such as atmospheric pressure, mass of clouds, and speed of the wind. Therapeutic administration of concentrations of inhaled NO < or = 5 ppm to critically ill patients did not affect the ambient concentration of NO and NO2 within the ICU, which was mainly dependent on the outdoor air pollution. As a consequence, scavenging of exhaust NO from the breathing circuit in the ventilator does not appear mandatory in ICUs located in areas with significant urban pollution when NO concentrations < or = 5 ppm are administered.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9372695     DOI: 10.1164/ajrccm.156.5.96-12012

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  4 in total

1.  A European survey of the use of inhaled nitric oxide in the ICU. Working Group on Inhaled NO in the ICU of the European Society of Intensive Care Medicine.

Authors:  S Beloucif; D Payen
Journal:  Intensive Care Med       Date:  1998-08       Impact factor: 17.440

2.  Workplace NO and NO2 during combined treatment of infants with nasal CPAP and NO.

Authors:  Robert Lindwall; Mats E Svensson; Claes G Frostell; Staffan Eksborg; Lars E Gustafsson
Journal:  Intensive Care Med       Date:  2006-10-17       Impact factor: 17.440

Review 3.  Inhaled nitric oxide: role in the pathophysiology of cardio-cerebrovascular and respiratory diseases.

Authors:  Lorenzo Berra; Emanuele Rezoagli; Davide Signori; Aurora Magliocca; Kei Hayashida; Jan A Graw; Rajeev Malhotra; Giacomo Bellani
Journal:  Intensive Care Med Exp       Date:  2022-06-27

4.  Non-invasive inhaled nitric oxide in the treatment of hypoxemic respiratory failure in term and preterm infants.

Authors:  R Sahni; X Ameer; K Ohira-Kist; J-T Wung
Journal:  J Perinatol       Date:  2016-10-06       Impact factor: 2.521

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.